Sidra Medicine to introduce gene-editing therapy for sickle cell disease, thalassemia

DOHA: Sidra Medicine, a member of Qatar Foundation, announced that it has been qualified by Vertex Pharmaceuticals as one of a limited number of hospitals in the world to administe...

Go to News Site